Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (24 ops.)
Latest filing published 09 Dec 2025 for Akero Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleCatriona Yale
Insider track record
Disclosed buys
0
Disclosed sells
24
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Catriona Yale: trading record in brief
This profile gathers the share dealings of Catriona Yale in Akero Therapeutics, Inc., where the filings describe the role as senior executive. The record holds 52 filings, for trades running from 15 July 2021 to 9 December 2025.
No open-market purchase appears, only 24 sales worth €3.4M. The rest of the record consists of 7 share grants and 19 option exercises. In 2025 alone, the filings show no purchases and 4 sales.
The newest entry dates from 9 December 2025: a transaction, in Akero Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Catriona Yale
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations52 total
27,227 sharesCommon StockSEC:0001193125-25-312100:0
47,573 sharesCommon StockSEC:0001193125-25-312100:1
3,527 shares@ US$28.351.4% of flowCommon StockSEC:0001193125-25-268032:0
659 shares@ US$43.020.4% of flowCommon StockSEC:0000950170-25-114665:0
10,000 shares@ US$19.872.9% of flowCommon StockSEC:0000950170-25-097013:0
890 shares@ US$23.8680.3% of flowCommon StockSEC:0000950170-25-093322:0
1,633 shares@ US$54.841.4% of flowCommon StockSEC:0000950170-25-088636:0
10,000 shares@ US$21.103.2% of flowCommon StockSEC:0000950170-25-088207:0
2,803 shares@ US$53.9962.4% of flowCommon StockSEC:0000950170-25-085671:0
10,000 shares@ US$21.103.1% of flowCommon StockSEC:0000950170-25-074708:0
9,073 shares@ US$21.102.7% of flowCommon StockSEC:0000950170-25-054893:0
10,000 shares@ US$21.103.1% of flowCommon StockSEC:0000950170-25-041458:0
614 shares@ US$44.880.4% of flowCommon StockSEC:0000950170-25-039736:0
10,000 shares@ US$21.103.3% of flowCommon StockSEC:0000950170-25-024996:0
16,849 shares@ US$0.6150.2% of flowCommon StockSEC:0000950170-25-011445:0
49,074 shares@ US$21.1016.0% of flowCommon StockSEC:0000950170-25-011444:0
24,300 shares0Common StockSEC:0000950170-24-138146:0
2,810 shares@ US$30.791.3% of flowCommon StockSEC:0000950170-24-136019:0
9,061 shares@ US$21.102.9% of flowCommon StockSEC:0000950170-24-128994:0
8,761 shares@ US$27.6943.7% of flowCommon StockSEC:0000950170-24-128994:1
300 shares@ US$28.8230.1% of flowCommon StockSEC:0000950170-24-128994:2
10,000 shares@ US$0.6150.1% of flowCommon StockSEC:0000950170-24-124230:0
4,515 shares@ US$21.101.4% of flowCommon StockSEC:0000950170-24-120231:0
14,825 shares@ US$0.6150.1% of flowCommon StockSEC:0000950170-24-115138:0
5,500 shares@ US$0.6150.0% of flowCommon StockSEC:0000950170-24-108837:0
25 of 52 declarations
